NASDAQ:AMTI Applied Molecular Transport (AMTI) Stock Price, News & Analysis → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Buy AMTI with Qtrade Free AMTI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.26▼$0.2650-Day Range$0.16▼$0.3152-Week Range$0.13▼$0.84VolumeN/AAverage Volume470,969 shsMarket Capitalization$10.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get Applied Molecular Transport alerts: Email Address Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About Applied Molecular Transport Stock (NASDAQ:AMTI)Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. As of December 27, 2023, Applied Molecular Transport Inc. operates as a subsidiary of Cyclo Therapeutics, Inc.Read More Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. AMTI Stock News HeadlinesFebruary 9, 2024 | benzinga.comFounders Fund V, LP's Net WorthDecember 27, 2023 | finance.yahoo.comCyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.April 24, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.November 22, 2023 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHS, AMTI, ESMT, CNSLNovember 22, 2023 | finance.yahoo.comApplied Molecular Transport Insider Ups Holding By 239% During YearNovember 10, 2023 | finanznachrichten.deApplied Molecular Transport Inc.: Applied Molecular Transport Reports Third Quarter 2023 Financial ResultsNovember 9, 2023 | msn.comApplied Molecular Transport GAAP EPS of -$0.17 beats by $0.33November 9, 2023 | finance.yahoo.comApplied Molecular Transport Reports Third Quarter 2023 Financial ResultsApril 24, 2024 | Wealthpin Pro (Ad)One trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? October 19, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, ICPT, FNCBOctober 10, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, CHS, FNCB, ICPTSeptember 22, 2023 | barrons.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Applied Molecular Transport Inc. BuyoutSeptember 21, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPLK, CYTH, AMTI, EBCSeptember 21, 2023 | msn.comApplied Molecular to merge with Cyclo Therapeutics in all-stock dealSeptember 21, 2023 | marketwatch.comCyclo Therapeutics to Buy Applied Molecular Transport in Stock Swap >CYTH AMTISeptember 8, 2023 | fool.comApplied Molecular Transport (NASDAQ: AMTI)August 18, 2023 | finanznachrichten.deApplied Molecular Transport Inc.: Applied Molecular Transport Reports Second Quarter 2023 Financial ResultsAugust 14, 2023 | finance.yahoo.comApplied Molecular Transport Reports Second Quarter 2023 Financial ResultsMay 16, 2023 | finance.yahoo.comPositive Signs As Multiple Insiders Buy Applied Molecular Transport StockMay 16, 2023 | finance.yahoo.comPositive Signs As Multiple Insiders Buy Applied Molecular Transport Stock \May 12, 2023 | finanznachrichten.deApplied Molecular Transport Inc.: Applied Molecular Transport Reports First Quarter 2023 Financial ResultsMay 11, 2023 | finance.yahoo.comApplied Molecular Transport Reports First Quarter 2023 Financial ResultsApril 18, 2023 | seekingalpha.comAMTI Applied Molecular Transport Inc.March 28, 2023 | bizjournals.comCEO exits Peninsula biotech Applied Molecular Transport amid job cuts, search for 'strategic alternatives'March 28, 2023 | finanznachrichten.deApplied Molecular Transport Inc.: Applied Molecular Transport Announces Corporate Leadership Change and Process to Explore Strategic AlternativesMarch 28, 2023 | markets.businessinsider.com3 Analysts Have This to Say About Applied MolecularMarch 27, 2023 | markets.businessinsider.comApplied Molecular To Explore Strategic AlternativesSee More Headlines Receive AMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied Molecular Transport and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:AMTI CUSIPN/A CIK1801777 Webwww.appliedmt.com Phone650-392-0420FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.90) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-126,320,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-223.46% Return on Assets-126.91% Debt Debt-to-Equity RatioN/A Current Ratio4.99 Quick Ratio4.99 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.56 per share Price / Book0.17Miscellaneous Outstanding Shares41,337,000Free Float34,764,000Market Cap$10.87 million OptionableNot Optionable Beta2.28 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Shawn M. Cross (Age 56)CEO & Chairman Comp: $679.78kDr. Tahir Mahmood Ph.D. (Age 49)Co-Founder & Director Comp: $870.29kMr. Brandon Hants (Age 47)Chief Financial Officer Comp: $469.67kMr. Andrew H. ChangHead of Investor Relations & Corporate CommunicationsKey CompetitorsPHAXIAM TherapeuticsNASDAQ:PHXMPulmatrixNASDAQ:PULMTevogen BioNASDAQ:TVGNLianBioNASDAQ:LIANEterna TherapeuticsNASDAQ:ERNAView All CompetitorsInsidersShawn CrossSold 110,802 sharesTotal: $17,728.32 ($0.16/share)Tahir Ph.D. MahmoodSold 286,320 sharesTotal: $45,811.20 ($0.16/share)Brandon HantsSold 61,494 sharesTotal: $9,839.04 ($0.16/share)Shawn CrossSold 90,447 sharesTotal: $14,471.52 ($0.16/share)Brandon HantsSold 50,146 sharesTotal: $8,023.36 ($0.16/share)View All Insider Transactions AMTI Stock Analysis - Frequently Asked Questions How were Applied Molecular Transport's earnings last quarter? Applied Molecular Transport Inc. (NASDAQ:AMTI) released its earnings results on Wednesday, November, 10th. The company reported ($0.68) earnings per share for the quarter, missing analysts' consensus estimates of ($0.62) by $0.06. What other stocks do shareholders of Applied Molecular Transport own? Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Molecular Transport investors own include CVS Health (CVS), Home Depot (HD), Procter & Gamble (PG), RTX (RTX), Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Cisco Systems (CSCO), Johnson & Johnson (JNJ) and Resideo Technologies (REZI). When did Applied Molecular Transport IPO? Applied Molecular Transport (AMTI) raised $130 million in an IPO on Friday, June 5th 2020. The company issued 10,000,000 shares at a price of $12.00-$14.00 per share. BofA Securities, Jefferies and SVB Leerink served as the underwriters for the IPO. This page (NASDAQ:AMTI) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Molecular Transport Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
